ONMD
NASDAQOneMedNet Corp
News · 26 weeks31+40%
2026-01-182026-07-12
Mix2090d
- SEC Filings9(45%)
- Insider8(40%)
- Other3(15%)
Latest news
25 items- SECSEC Form 424B3 filed by OneMedNet Corp424B3 - OneMedNet Corp (0001849380) (Filer)
- SECSEC Form EFFECT filed by OneMedNet CorpEFFECT - OneMedNet Corp (0001849380) (Filer)
- SECAmendment: SEC Form S-1/A filed by OneMedNet CorpS-1/A - OneMedNet Corp (0001849380) (Filer)
- SECSEC Form S-1 filed by OneMedNet CorpS-1 - OneMedNet Corp (0001849380) (Filer)
- SECSEC Form 8-K filed by OneMedNet Corp8-K - OneMedNet Corp (0001849380) (Filer)
- INSIDERChief Executive Officer Green Aaron bought $21,011 worth of shares (36,650 units at $0.57), increasing direct ownership by 2% to 1,896,375 units (SEC Form 4)4 - OneMedNet Corp (0001849380) (Issuer)
- INSIDERChief Medical Officer Yu Jeffrey bought $100,000 worth of shares (158,730 units at $0.63), increasing direct ownership by 2% to 8,780,410 units (SEC Form 4)4 - OneMedNet Corp (0001849380) (Issuer)
- INSIDERChief Medical Officer Yu Jeffrey bought $100,000 worth of shares (172,414 units at $0.58), increasing direct ownership by 2% to 8,621,680 units (SEC Form 4)4 - OneMedNet Corp (0001849380) (Issuer)
- INSIDERChief Executive Officer Green Aaron bought $30,697 worth of shares (55,622 units at $0.55), increasing direct ownership by 3% to 1,859,725 units (SEC Form 4)4 - OneMedNet Corp (0001849380) (Issuer)
- INSIDERDirector Kosasa Thomas bought $100,000 worth of shares (158,730 units at $0.63), increasing direct ownership by 0.94% to 17,088,874 units (SEC Form 4)4 - OneMedNet Corp (0001849380) (Issuer)
- PROneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025MINNEAPOLIS, June 10, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-driven Real-World Data (RWD), today announced it has secured more than $3 million in new bookings to date for 2026 as of this announcement – surpassing the Company's total bookings for all of full-year 2025. The Company expects to recognize substantially all of these bookings as revenue by the end of the third quarter of 2026. This milestone reflects strong commercial traction for OneMedNet's iRWD™ Platform, powered by Palantir Foundry. Life sciences organizations are increasingly turning to the Company's
- PROneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its NetworkMINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-Driven Real-World Data (RWD), today announced that its OneMedNet iRWD™ Network, has surpassed 90 million patient journeys and 270 million studies, with a healthcare partner network now exceeding 2,300 sites. The milestone represents direct progress against the strategic priorities the Company laid out to shareholders at the close of 2025, when OneMedNet identified expansion of its data network as a core pillar of long-term value creation. Today's announcement reflects the team's disciplined execution ag
- INSIDERDirector Kosasa Thomas bought $250,000 worth of shares (268,817 units at $0.93), increasing direct ownership by 2% to 16,930,144 units (SEC Form 4)4 - OneMedNet Corp (0001849380) (Issuer)
- SECSEC Form 424B3 filed by OneMedNet Corp424B3 - OneMedNet Corp (0001849380) (Filer)
- SECSEC Form 10-Q filed by OneMedNet Corp10-Q - OneMedNet Corp (0001849380) (Filer)
- SECAmendment: SEC Form 10-K/A filed by OneMedNet Corp10-K/A - OneMedNet Corp (0001849380) (Filer)
- INSIDERChief Medical Officer Yu Jeffrey was granted 219,429 shares and bought $750,000 worth of shares (903,614 units at $0.83), increasing direct ownership by 15% to 8,449,266 units (SEC Form 4)4 - OneMedNet Corp (0001849380) (Issuer)
- INSIDERDirector Kosasa Thomas bought $749,999 worth of shares (876,136 units at $0.86), increasing direct ownership by 6% to 16,661,327 units (SEC Form 4)4 - OneMedNet Corp (0001849380) (Issuer)
- PROneMedNet Goes Live with 80 Million Patient Journeys and Billions of RecordsMINNEAPOLIS, April 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-Driven Real-World Data (RWD), today announced that its OneMedNet iRWD™ Platform, built on Palantir Foundry, is now live and fully operational. This major commercialization milestone delivers searchable access to billions of records across 80 million patient journeys in seconds, transforming how life sciences organizations access and analyze multi-modal clinical data at unprecedented scale and speed. Key Commercial Milestones of iRWD™ Platform: OneMedNet iRWD™ Platform Now Live on Palantir Foundry~70%
- SECOneMedNet Corp filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - OneMedNet Corp (0001849380) (Filer)
- PROneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical DataMINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-Driven Real-World Data (RWD), highlights its 2025 results, with robust revenue growth from the prior year, a strengthened balance sheet, and continued commercial momentum driven by Palantir Foundry enabled conversational search on Real-Time medical data from OneMedNet's rapidly growing network. 2025 Financial Highlights: RWD Revenue Growth: RWD revenue increased 329% year-over-year, rising from $292,000 in 2024 to $1,254,000 in 2025, reflecting strong market demand and increased commercial traction.
- PROneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AIMINNEAPOLIS, April 01, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD), is pleased to announce that Inka Health, a wholly-owned subsidiary of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) has entered into a collaboration with OneMedNet Inc., under which Onco-Innovations and Inka Health will have access to OneMedNet's iRWD™ platform— powered by Palantir (PLTR) Foundry— providing it access to U.S. real-world oncology data. The agreement is intended to accelerate development timelines, reduce clinical and re
- SECSEC Form 424B3 filed by OneMedNet Corp424B3 - OneMedNet Corp (0001849380) (Filer)
- SECSEC Form 10-K filed by OneMedNet Corp10-K - OneMedNet Corp (0001849380) (Filer)
- PROneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data InsightsMINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD), today announced a strategic collaboration with Navidence to help research organizations transform rapidly expanding healthcare data into clear, actionable real-world evidence. What This Collaboration Means for the Pharma Market Pharmaceutical companies face growing pressure to integrate high-quality RWD for regulatory submissions, post-market surveillance, and AI model training. Navidence's platform enables precise definition of health data needs via Computable Operationa
ONMD FAQ
5 questionsWhere does ONMD stock trade?
OneMedNet Corp (ONMD) is listed on NASDAQ.What sector and industry is ONMD in?
OneMedNet Corp operates in the Health Care sector, Biotechnology: Commercial Physical & Biological Resarch industry.When did OneMedNet Corp go public?
OneMedNet Corp (ONMD) completed its IPO in 2021.What companies are similar to ONMD?
Notable peers in the same industry include IQV (IQVIA Holdings Inc.), INCY (Incyte Corp.), PPD (PPD, Inc.), MEDP (Medpace Holdings Inc.), ICLR (ICON plc). Compare ONMD side-by-side with any of them on Quantisnow.How can I track ONMD on Quantisnow?
Quantisnow aggregates OneMedNet Corp's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ONMD to receive live email and push alerts on every new disclosure.